Larotrectinib Oral Solution and Measles virus vaccine, live Subcutaneous
Determining the interaction of Larotrectinib Oral Solution and Measles virus vaccine, live Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: measles virus vaccine
Brand name:
Synonyms: Measles virus vaccine, live (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Oral Solution-Measles, mumps, and rubella (MMR) vaccine
- Larotrectinib Oral Solution-Measles, Mumps, and Rubella Vaccine
- Larotrectinib Oral Solution-Measles, Mumps, and Rubella Virus Vaccine
- Larotrectinib Oral Solution-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular
- Larotrectinib Oral Solution-Measles, mumps, rubella and varicella (MMRV) vaccine
- Larotrectinib Oral Solution-Measles, Mumps, Rubella, and Varicella Virus Vaccine
- Measles virus vaccine, live Subcutaneous-Larotrectinib Sulfate
- Measles virus vaccine, live Subcutaneous-Lartruvo
- Measles virus vaccine, live Subcutaneous-Larynex
- Measles virus vaccine, live Subcutaneous-Laryng-O-Jet
- Measles virus vaccine, live Subcutaneous-Laryngesic
- Measles virus vaccine, live Subcutaneous-Lasix